TransNanoAvansens is an interdisciplinary and inter-institutional consortium with proven scientific experience shared over the last eight years in previous support programmes for R&D activities between research groups of the Community of Madrid in Technologies (AVANSENS – S2009/PPQ-1642 and NANOAVANSENS – S2013/MIT-3029)
It is made up of six research groups and 10 companies associated with the project, 8 of which are based in the Community of Madrid. Hospital (Ramón y Cajal, La Paz and Clínico de San Carlos Hospitals) and diagnostic entities (Centre for the Diagnosis of Metabolic Diseases, CEDEM, of the UAM) also participate, whose collaboration is essential in achieving the central objective of the Programme.